Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMIYTPE)

Drug Name

Apolipoprotein E Drug Info

Synonyms

Apolipoprotein E, Bio-Technology General; Apo-A4, Bio-Technology General; Apo-E, Bio-Technology General; Apolipoprotein-A4, Bio-Technology General

Indication

Disease Entry	ICD 11	Status	REF
Glaucoma/ocular hypertension	9C61	Terminated	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Apolipoprotein E (APOE)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AEM-28	DMI5TXZ	Familial hypercholesterolemia	5C80.00	Phase 2	[3]
CN-105	DM0MTP8	Nontraumatic intracerebral hemorrhage	8B00.4	Phase 2	[4]
LX1001	DMXEJZO	Alzheimer disease	8A20	Phase 1/2	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000261)
2	Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 1994 Mar;54(3):299-308.
3	Clinical pipeline report, company report or official report of LipimetiX.
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5	Clinical pipeline report, company report or official report of Lexeo Therapeutics